Mirum Pharmaceuticals, Inc.
MIRM
$102.19
-$9.21-8.26%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 386.26M | 383.33M | 375.55M | 304.55M | 277.67M |
| Total Receivables | 133.11M | 123.33M | 107.13M | 106.84M | 95.85M |
| Inventory | 25.52M | 24.89M | 24.02M | 22.94M | 22.42M |
| Prepaid Expenses | 24.55M | 18.14M | 23.87M | 19.07M | 14.87M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 569.44M | 549.68M | 530.58M | 453.40M | 410.82M |
|
|
|||||
| Total Current Assets | 569.44M | 549.68M | 530.58M | 453.40M | 410.82M |
| Net Property, Plant & Equipment | 15.06M | 10.60M | 9.78M | 10.12M | 8.77M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 254.15M | 260.92M | 231.90M | 237.87M | 243.85M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 17.91M | 13.50M | 10.40M | 7.32M | 5.90M |
| Total Assets | 890.92M | 842.81M | 785.12M | 725.83M | 690.25M |
|
|
|||||
| Total Accounts Payable | 59.40M | 9.61M | 12.17M | 17.66M | 11.64M |
| Total Accrued Expenses | 122.48M | 105.56M | 87.89M | 72.18M | 64.07M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.35M | 2.14M | 2.04M | 2.08M | 1.64M |
| Total Finance Division Other Current Liabilities | 88.60M | 88.48M | 58.26M | 52.88M | 50.22M |
| Total Other Current Liabilities | 88.60M | 88.48M | 58.26M | 52.88M | 50.22M |
| Total Current Liabilities | 272.82M | 205.80M | 160.36M | 144.80M | 127.58M |
|
|
|||||
| Total Current Liabilities | 272.82M | 205.80M | 160.36M | 144.80M | 127.58M |
| Long-Term Debt | 310.25M | 309.80M | 309.37M | 308.93M | 308.51M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 11.18M | 7.52M | 7.36M | 7.88M | 7.00M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 54.17M | 5.01M | 15.98M | 9.05M | 13.90M |
| Total Liabilities | 648.42M | 528.12M | 493.07M | 470.67M | 456.99M |
|
|
|||||
| Common Stock & APIC | 1.70B | 981.88M | 953.82M | 919.53M | 892.37M |
| Retained Earnings | -1.46B | -667.54M | -661.81M | -664.72M | -658.86M |
| Treasury Stock & Other | -28.00K | 351.00K | 37.00K | 352.00K | -258.00K |
| Total Common Equity | 242.49M | 314.69M | 292.05M | 255.16M | 233.26M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 242.49M | 314.69M | 292.05M | 255.16M | 233.26M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 242.49M | 314.69M | 292.05M | 255.16M | 233.26M |
|
|
|||||